I
nflammatory bowel disease (IBD) affects many women of reproductive age, making the interaction of this disease with pregnancy and childbirth an important consideration. Previous studies have suggested that patients with ulcerative colitis (UC) and Crohn's disease (CD) have a higher incidence of cesarean delivery compared with women without IBD. [1] [2] [3] [4] [5] [6] [7] [8] [9] Population-based studies have shown that this increased risk of cesarean delivery exists for both unscheduled and scheduled procedures. 3, 7 In contrast to these observations, recent data and expert consensus suggest that vaginal delivery is safe for most patients, and mode of delivery should be determined by obstetric indications and patient preference. [10] [11] [12] [13] [14] Current European 14 and Toronto 13 guidelines designate only active perianal disease as a definite indication and ileal pouch-anal anastomosis (IPAA) as a relative indication for cesarean delivery. It is unclear if these subpopulations alone drive the increased incidence of cesarean delivery in patients with IBD, or if there are other risk factors for cesarean delivery in the IBD population.
The concern regarding vaginal delivery after IPAA is that it may lead to occult anal sphincter injury and worsen fecal incontinence. 15, 16 Several studies, however, have yielded conflicting results regarding these outcomes. 14, [17] [18] [19] [20] The presence of active perianal disease is also of concern in vaginal delivery, as a vaginal trauma or laceration at the time of delivery may hypothetically lead to progressive perianal symptoms or nonhealing fistula in a patient with active perianal CD. As such, cesarean delivery is recommended for patients with active perianal disease. 13, 14 Ilnychyj et al 3 found that among women with CD, all the women with active perianal disease at the time of vaginal delivery (4 of 15) reported subjective worsening of perianal symptoms postpartum. The women with inactive perianal disease (11 of 15) had no relapse of disease within one-year postpartum. 3 Patients with inactive perianal disease are not considered at increased risk of fistula development or disease flare if they undergo a vaginal delivery, and mode of delivery is often left up to the treating obstetrician.
We undertook this study to compare the incidence of cesarean delivery between women with UC and CD and women without IBD, and to identify indications for cesarean delivery among women with IBD to better assess the underlying driving factors for mode of delivery. We evaluated whether cesarean deliveries were planned or unplanned.
MATERIALS AND METHODS
We performed a retrospective cohort study of all nulliparous women (women who had not previously given birth) who delivered a singleton infant at our medical center from 2003 through 2013. Women who had previously given birth and those pregnant with more than one fetus were excluded from the study, as these factors are independent risk factors for cesarean delivery. However, women with previous pregnancies (nonprimigravidae) who had never given birth (i.e., experienced spontaneous or planned abortions) were included. We identified women with IBD by ICD-9 codes (556.x and 555.x). Women identified as having IBD were excluded if they did not have gastroenterology chart documentation or if they were diagnosed with IBD after delivery. All patients included were assessed by a gastroenterologist at minimum before pregnancy and after delivery. Clinical assessments during pregnancy and at delivery were made by gastroenterology and obstetrics at variable time points based on clinical need and practice.
We obtained demographic information, obstetric provider, and mode of delivery from medical records for all women. For women with IBD, we also extracted data on comorbidities known to be associated with cesarean delivery (including diabetes and smoking), pregnancy course, planned and actual mode of delivery, and indication for cesarean delivery. In addition, we retrieved IBD-specific data including the following: location and type of IBD; medications and disease activity before pregnancy (within 6 months before conception), during pregnancy (anytime during pregnancy or at time of delivery), and after pregnancy (within 3 months of delivery); and whether the gastroenterologist was a generalist or IBD subspecialist. The charts were reviewed to determine disease activity, defined as active versus inactive by the treating physician.
A cesarean delivery was classified as planned if that was the intended mode of delivery, regardless of whether the delivery occurred on the originally planned date. All other cesarean deliveries were deemed unplanned. The indication for cesarean delivery was noted, and each indication was categorized into one of 10 encompassing IBD-related or non-IBD-related indication groups.
We used the chi-square or Fisher's exact test to compare categorical data and a t test or Wilcoxon rank-sum test to compare continuous data, depending on normality of the distribution. We used modified Poisson regression 21 to calculate risk ratios (RRs) and 95% confidence intervals. We considered demographic Data are presented as mean 6 SD or n (%).
characteristics, medication use, and disease activity before and during pregnancy, as well as at time of delivery, as potential confounders. Variables that altered the RR by more than 10% were retained in the model. All tests were 2-sided, and P-values ,0.05 were considered statistically significant.
Ethical Considerations
Our institutional review board approved the study.
RESULTS

Baseline Characteristics
During the 10-year study period, 21,929 nulliparous women delivered singleton infants at our institution. Of these women, 176 (0.8%) had IBD. Thirty-six women without sufficient gastroenterology chart documentation to assess disease status and 16 women diagnosed with IBD after delivery were excluded, yielding 124 subjects with IBD (59 with CD and 65 with UC). Women with CD and UC were more likely to be non-Hispanic white (89.8% and 80.0%, respectively) compared with women without IBD (55.3%; both P , 0.01). Compared with women without IBD (77.7%), women with UC were more likely to be primigravid (89.2%; P ¼ 0.03). In addition, women with CD were more likely to have private insurance (89.8% versus 77.1%; P ¼ 0.02). See Table 1 for baseline characteristics.
Half (49.2%) of women with CD had ileocolonic involvement, and 18.6% had a history of perianal disease. Most women with UC had left-sided disease (32.3%) or pancolitis (36.9%), and 15.4% had undergone IPAA. Twenty-four percent of women with CD and 41.5% of women with UC had active disease during pregnancy. Four of 11 patients (36.3%) with perianal disease experienced active disease during pregnancy. Other disease characteristics of the women with IBD are presented in Table 2 .
Incidence of Cesarean Delivery in Patients with IBD
Mode of delivery in patients without IBD, with UC, and with CD is shown in Table 3 . Of 21,805 patients without IBD, 7868 (36.1%) underwent cesarean delivery. Women with UC were significantly more likely to have a cesarean delivery (41/ 65; 63.1%) compared with women without IBD (P , 0.001), yielding a nearly 2-fold increased risk (RR: 1.8; 95% confidence interval, 1.5-2.1). All women with UC and an IPAA underwent cesarean delivery, and therefore had a notably higher incidence of cesarean delivery compared with women without IBD. Though fewer women with UC without IPAA underwent cesarean delivery (54.7%), this incidence was also higher than among women without IBD (P , 0.01). Adjusting for maternal age, race, insurance status, rectal medication use, and gravidity did not appreciably alter the associations. Crude associations are presented in Figure 1 .
Among women with CD, 24/59 (40.7%) had a cesarean delivery, which was similar to the incidence among women without IBD (36.1%; P ¼ 0.46), yielding an RR of 1.1 (95% confidence interval, 0.83-1.5). Most (83.3%) women with CD and a history of perianal disease (either active or inactive during pregnancy) had a cesarean delivery, which was significantly higher than among women without IBD (P ¼ 0.03). Only 2 women in this cohort had active perianal disease at the time of delivery. Among those without a history of perianal disease, the incidence of cesarean delivery (37.0%) was similar to women without IBD (P ¼ 0.89). As with the UC models, adjusting for potential confounders did not appreciably alter the associations. Crude associations are presented in Figure 1 .
Indications and Risk Factors for Cesarean Delivery in Women with IBD
The indications for cesarean delivery among women with IBD are shown in Table 4 . Of the 41 cesarean deliveries in women with UC, 21 (51.2%) were planned, and 20 (48.8%) were unplanned. Just over half (52.4%) of the planned cesarean deliveries for UC were for an IBD-related indication, with 28.6% for a history of IBD (not active at the time of delivery), and 23.8% for history of IPAA. By contrast, none of the unplanned cesarean deliveries were for an IBD-related indication, with 9 (45.0% of unplanned deliveries) for arrest of descent/dilation, 10 (50.0%) for nonreassuring fetal heart tracings, and 1 (5%) for nonvertex presentation. No patient with active UC underwent cesarean delivery.
Of the 24 cesarean deliveries among women with CD, 8 (33.3%) were planned, and 16 (66.7%) were unplanned. Six (75%) of the planned cesarean deliveries were for an IBD-related indication (62.5% for a history of perianal CD and 12.5% for active disease at the time of delivery), whereas only 1 (6.3%) of the unplanned cesarean deliveries was for an IBD-related indication (P ¼ 0.001). Most unplanned cesarean deliveries in patients with CD were for arrest of descent/dilation (43.8% of unplanned deliveries) and nonreassuring fetal heart tracings (31.3%). The 1 unplanned cesarean delivery for an IBD-related indication occurred in a woman with a Crohn's flare and clinical evidence of peritonitis.
The incidence of cesarean delivery was not related to disease activity. Among women with UC, 17 (63.0%) of those who had active disease during pregnancy had a cesarean delivery compared with 23 (62.2%) of those who did not have active disease (P ¼ 0.95). Of the 17 women who had a cesarean delivery and active disease during pregnancy, 9 (52.9%) had an unplanned cesarean delivery, none for the indication of IBD. Although this incidence was higher than the incidence among the 23 women with UC and without active disease (43.5%), the difference was not statistically significant (P ¼ 0.79). Among women with CD, 8 (57.1%) of those who had active disease during pregnancy had a cesarean delivery compared with 15 (36.6%) of those without active disease (P ¼ 0.41). Of the 8 women with active disease during pregnancy who had a cesarean delivery, 4 (50.0%) had an unplanned cesarean delivery, which was not significantly different from the proportion among women with CD who did not have active disease (73.3%; P ¼ 0.42). Only 1 unplanned cesarean delivery in women with CD was for the indication of IBD.
DISCUSSION
Several studies have specifically examined the effect of perianal CD and IPAA on mode of delivery, 3, 11, 12, 15, 18 but, to our knowledge, this is the first U.S. study to examine the full distribution of indications for cesarean delivery among women with IBD and whether they were planned or unplanned. We confirmed 13, 14 where IPAA is a relative indication for cesarean delivery, all patients with an IPAA underwent cesarean delivery. All patients with active perianal disease at the time of delivery underwent cesarean delivery as well. However, 5 of 8 (62.5%) patients with CD underwent planned cesarean delivery for a history of inactive perianal CD, and 6 of 21 (28.6%) patients with UC underwent planned cesarean delivery for a history of IBD, though they experienced no active disease during pregnancy. The indication for these deliveries diverges from current guidelines, though the extent of divergence seems consistent with other recent findings of cesarean delivery for IBD. In a recent study by Cheng et al, 24 50 (82%) of 61 patients with perianal CD underwent cesarean delivery, though only 3 were noted to have active perianal disease during pregnancy. These data provide a real-world assessment of adherence to delivery guidelines in IBD. In this population, we are unable to conclude whether cesarean deliveries that diverged from guidelines were avoidable, as there may have been clinical factors in this tertiary care population for which we could not account that impacted clinical decision making.
These data must be interpreted in the context of the study design and patient population. Despite a 10-year follow-up period, the number of singleton births in nulliparous women with IBD in this single-center study was low, limiting the power of our study to detect differences across outcomes. Most of our participants were white, and a large proportion was cared for by maternal-fetal medicine providers at our tertiary care center, possibly limiting the generalizability of our findings. Patients seem to have had relatively mild disease, marked by the low proportion of patients followed by an IBD specialist as compared to general gastroenterologist. Antitumor necrosis factor therapy use also was low in our cohort, which may reflect the overall severity of disease in this cohort or concern regarding medication use in pregnancy. Though our demographic, pregnancy-related, and medication variables could be abstracted from medical records, our ability to define and capture active disease or flare was solely based on expert physician impression on chart review. The incidence of unplanned cesarean deliveries in the IBD population was higher than expected, 22,23 but we are unable to further evaluate this finding as we do not have similar data for women without IBD.
In summary, patients with UC (with and without IPAA) and active or inactive perianal CD are at increased risk of cesarean delivery in comparison with the general population. Most planned cesarean deliveries were for the indication of IBD. However, more than half of cesarean deliveries were unplanned, with only 1 unplanned cesarean delivery performed in our population for the indication of IBD. Subclinical inflammation or other unmeasured factors may account for the high rate of unplanned cesarean delivery and should be addressed in future studies.
